NuCana (NCNA) Assets Average (2017 - 2025)
NuCana's (NCNA) quarterly Assets Average came in at $41.6 million in Q4 2025, up 87.83% year-on-year from $22.2 million in Q4 2024, and up 27.66% quarter-over-quarter from $32.6 million in Q3 2025.
NuCana (NCNA) Assets Average (2017 - 2025) Analysis & Trends
NuCana has disclosed Assets Average across 9 years of filings, most recently posting $41.6 million for Q4 2025.
- Assets Average for Q4 2025 came in at $41.6 million, up 87.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $41.6 million (up 87.83% YoY), and the FY2025 annual result was $29.1 million, up 8.87% from the prior year.
- Assets Average came in at $41.6 million for Q4 2025 at NuCana, up from $32.6 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $140.7 million in Q1 2021 to a low of $16.8 million in Q1 2025.
- The 5-year median for Assets Average is $51.4 million (2023), against an average of $64.3 million.
- Peak annual rise in Assets Average reached 87.83% in 2025, while the deepest fall reached 49.11% in 2025.
- NuCana's Assets Average stood at $114.1 million in 2021, then tumbled by 34.6% to $74.6 million in 2022, then slumped by 48.04% to $38.8 million in 2023, then plunged by 42.82% to $22.2 million in 2024, then surged by 87.83% to $41.6 million in 2025.
- The last three Assets Average figures came in at $41.6 million (Q4 2025), $32.6 million (Q3 2025), and $18.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 660.38 Mn |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | 41.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.64 Mn |
| Sep 30, 2025 | 32.62 Mn |
| Jun 30, 2025 | 18.12 Mn |
| Mar 31, 2025 | 16.79 Mn |
| Dec 31, 2024 | 22.17 Mn |
| Sep 30, 2024 | 25.36 Mn |
| Jun 30, 2024 | 28.40 Mn |
| Mar 31, 2024 | 32.99 Mn |
| Dec 31, 2023 | 38.77 Mn |
| Sep 30, 2023 | 47.33 Mn |
| Jun 30, 2023 | 55.44 Mn |
| Mar 31, 2023 | 63.79 Mn |
| Dec 31, 2022 | 74.62 Mn |
| Sep 30, 2022 | 82.41 Mn |
| Jun 30, 2022 | 89.87 Mn |
| Mar 31, 2022 | 100.14 Mn |
| Dec 31, 2021 | 114.11 Mn |
| Sep 30, 2021 | 126.41 Mn |
| Jun 30, 2021 | 134.07 Mn |
| Mar 31, 2021 | 140.71 Mn |